A phase 2 study of talimogene laherparepvec, nivolumab, and trabectedin (TNT) in advanced sarcoma.

Authors

null

Neal Shiv Chawla

City of Hope Comprehensive Cancer Center, Duarte, CA

Neal Shiv Chawla , Ted Kim , Travis Sherman , Jonathan Dang , Victoria S. Chua , Ania Moradkhani , Ishrat Bhuiyan , Nathalie Krkyan , Mitchel Fernando , Emma Colletti , William Feske , Kitty Zheng , Warren Allen Chow , Mark Agulnik , Doris Quon , Sant P. Chawla , Erlinda Maria Gordon , Arun S. Singh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03886311

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 11567)

DOI

10.1200/JCO.2021.39.15_suppl.11567

Abstract #

11567

Poster Bd #

Online Only

Abstract Disclosures